Variable Methylation Potential in Preterm Placenta: Implication for Epigenetic Programming of the Offspring

Vinita V Khot1, Preeti Chavan-Gautam1, Savita Mehendale2

  • 11 Department of Nutritional Medicine, Interactive Research School for Health Affairs, Pune, Maharashtra, India.

Insights

Preterm birth is linked to later noncommunicable diseases. This study found lower methylation potential in preterm placentas, potentially impacting fetal epigenetic programming and future health.

Area of Science:

  • Epigenetics
  • Developmental Biology
  • Nutritional Science

Background:

  • Children born preterm face higher risks for adult noncommunicable diseases.
  • Placental DNA methylation patterns are crucial for fetal programming of adult diseases.
  • Micronutrients and long-chain polyunsaturated fatty acids (LCPUFAs) influence methylation via the 1-carbon cycle.

Purpose of the Study:

  • To investigate the impact of preterm birth on placental methylation potential.
  • To examine mRNA and protein levels of key enzymes (MAT2A, AHCY) in the S-adenosylmethionine pathway.
  • To assess S-adenosylmethionine (SAM), S-adenosylhomocysteine (SAH) levels, and global DNA methylation in preterm and term placentae.

Main Methods:

  • Real-time quantitative polymerase chain reaction (qPCR) for mRNA analysis.
  • Enzyme-linked immunosorbent assay (ELISA) for protein quantification.
  • High-performance liquid chromatography (HPLC) for SAM and SAH level determination.

Main Results:

  • Higher mRNA levels of MAT2A and AHCY were observed in preterm placentae.
  • The SAM:SAH ratio was lower in the preterm group.
  • Increased global DNA methylation was found in placentae of small for gestational age infants.

Conclusions:

  • Preterm placentae exhibit altered enzyme expression and a reduced methylation potential.
  • These epigenetic changes may contribute to the increased risk of noncommunicable diseases in individuals born preterm.
  • Findings highlight the role of placental epigenetics in fetal programming and long-term health outcomes.

Related Concept Videos

Genomic Imprinting and Inheritance02:30

Genomic Imprinting and Inheritance

Diploid organisms inherit genetic material through chromosomes from both parents. Copies of the same gene are known as alleles. In most cases, both alleles are simultaneously expressed and allow various cellular processes to function optimally. If one of the alleles is missing or mutated, the expression of the other allele can compensate; however, this is not true for all genes.
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
38.5K
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
4.1K
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
34.2K
Chromatin Modification in iPS Cells01:32

Chromatin Modification in iPS Cells

Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
2.3K
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.4K
Phase II Reactions: Methylation Reactions01:17

Phase II Reactions: Methylation Reactions

Methylation is a phase II biotransformation process involving the attachment of a methyl group to a substrate. Enzymes known as methyltransferases orchestrate this reaction.
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
845